These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. Jarde A; Lutsiv O; Beyene J; McDonald SD BJOG; 2019 Apr; 126(5):556-567. PubMed ID: 30480871 [TBL] [Abstract][Full Text] [Related]
7. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. O'Brien JM; Lewis DF Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340 [TBL] [Abstract][Full Text] [Related]
8. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis. Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009 [TBL] [Abstract][Full Text] [Related]
9. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007 [TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866 [TBL] [Abstract][Full Text] [Related]
11. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885 [TBL] [Abstract][Full Text] [Related]
13. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial. Crowther CA; Ashwood P; McPhee AJ; Flenady V; Tran T; Dodd JM; Robinson JS; PLoS Med; 2017 Sep; 14(9):e1002390. PubMed ID: 28949973 [TBL] [Abstract][Full Text] [Related]
14. Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol. Stewart LA; Simmonds M; Duley L; Dietz KC; Harden M; Hodkinson A; Llewellyn A; Sharif S; Walker R; Wright K; Syst Rev; 2017 Nov; 6(1):235. PubMed ID: 29183399 [TBL] [Abstract][Full Text] [Related]
15. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208 [TBL] [Abstract][Full Text] [Related]
16. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth. Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230 [TBL] [Abstract][Full Text] [Related]
17. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis. Conde-Agudelo A; Romero R; Rehal A; Brizot ML; Serra V; Da Fonseca E; Cetingoz E; Syngelaki A; Perales A; Hassan SS; Nicolaides KH Am J Obstet Gynecol; 2023 Dec; 229(6):599-616.e3. PubMed ID: 37196896 [TBL] [Abstract][Full Text] [Related]
18. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial. Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909 [TBL] [Abstract][Full Text] [Related]
19. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis. Care A; Nevitt SJ; Medley N; Donegan S; Good L; Hampson L; Tudur Smith C; Alfirevic Z BMJ; 2022 Feb; 376():e064547. PubMed ID: 35168930 [TBL] [Abstract][Full Text] [Related]
20. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Dodd JM; Jones L; Flenady V; Cincotta R; Crowther CA Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004947. PubMed ID: 23903965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]